This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Cost data:
The health service costs were those of contraceptive provision (drugs, health professionals' time and equipment for insertion and removal of IUD, LIUS, and ESI) and those associated with the outcomes of unintended pregnancy. The patterns of resource consumption were based on experts' opinions, supplemented with UK national reports. The unit costs were derived from British national sources. All costs were in UK pounds sterling (£) and the price year was 2005. A 3.5% annual discount rate was applied to those costs incurred after the first year.
Analysis of uncertainty:
A series of one-and two-way sensitivity analyses were carried out using published confidence intervals (for failure rates and discontinuation rates) or ranges set by the authors (for the costs of all methods). Alternative scenarios were considered with different assumptions on the use of COC, the LARC method discontinuation, the replacement of the IUD device, and other model inputs.
Results
For between 2 and 15 years of use, all LARC methods dominated the COC, which means they were more effective and less costly. The incremental cost per pregnancy averted with female sterilisation compared with LARC reached a maximum of £38,197 over the first four years of treatment, but for six years of contraceptive protection and above, female sterilisation became dominant over all LARC methods.
In the comparison among LARC methods, for between 2 and 15 years of use, the DMPA was dominated by the other LARC methods. The LIUS was dominated across all time frames. The incremental cost-effectiveness ratio of the ESI over the IUD was £13,206 per pregnancy averted, at one year of use, but gradually decreased as the years of intended use increased (except for slight increases at 4, 7, 10 and 13 years). At 15 years of contraceptive use, the ESI dominated the IUD.
The sensitivity analysis showed that these findings were sensitive to the assumptions on the perfect use of the COC and the rate of discontinuation with LARC. However, LARC methods dominated the COC, under most scenarios, and they were dominant over female sterilisation, when the LARC discontinuation rate was zero.
Authors' conclusions
The authors concluded that LARC methods were cost-effective for preventing pregnancy from the British NHS perspective. They pointed out that future studies should identify ways to increase the acceptability and reduce the discontinuation rate for LARC methods.
CRD commentary

Interventions:
The rationale for the selection of the comparators was clearly explained and discussed. Only strategies that depended exclusively on the women's choice and compliance were considered.
Effectiveness/benefits:
The use of a systematic literature review to identify the relevant sources of data was the optimal strategy for a decision analytic framework. However, the methods and conduct of the review were not reported. The authors provided some information on the design of their sources and these appear to have been valid. RCTs were appropriately selected to derive the treatment efficacy, while cohort studies were used to obtain real-world data on the treatment patterns and discontinuation rates. Pregnancies avoided are a commonly used benefit measure for contraceptive strategies, but a measure such as this is difficult to compare with the benefits of other health care interventions and it is also difficult to put a monetary value on an unintended pregnancy. The lack of data, on the quality of life associated with this outcome, rules out the possibility of using a more comprehensive and comparable benefit measure.
Costs:
The categories of costs were consistent with the perspective. However, they were only presented as macro-categories and no details on the relative impact of each of these cost items were given. The sources of costs were reported and were consistent with the perspective. Other details such as the use of discounting, price year, and use of sensitivity analyses on the economic estimates were reported.
